Insider Deal: John Battelle Picked up 100 Shares of Acxiom (ACXM); Repros Therapeutics (RPRX) Sentiment Is 0.7

Acxiom Corporation (NASDAQ:ACXM) Logo

Sentiment for Repros Therapeutics Inc (RPRX)

Repros Therapeutics Inc (RPRX) investors sentiment increased to 0.7 in Q4 2017. It’s up 0.12, from 0.58 in 2017Q3. The ratio has improved, as 7 hedge funds started new and increased stock positions, while 10 decreased and sold positions in Repros Therapeutics Inc. The hedge funds in our database reported: 3.96 million shares, down from 4.93 million shares in 2017Q3. Also, the number of hedge funds holding Repros Therapeutics Inc in top ten stock positions was flat from 0 to 0 for the same number . Sold All: 3 Reduced: 7 Increased: 3 New Position: 4.

The stock decreased 0.96% or $0.0065 during the last trading session, reaching $0.67. About 251,774 shares traded. Repros Therapeutics Inc. (RPRX) has 0.00% since March 30, 2017 and is . It has underperformed by 11.55% the S&P500.

Repros Therapeutics Inc., a biopharmaceutical company, focuses on the development of various drugs to treat hormonal and reproductive system disorders for male and female in the United States. The company has market cap of $26.51 million. The Company’s product portfolio include Proellex that is in Phase III clinical trials for the treatment of symptoms associated with uterine fibroids, as well as in Phase II clinical trial for the treatment of endometriosis; and enclomiphene, a single isomer of clomiphene citrate, which is in Phase III clinical trials for the treatment of secondary hypogonadism in overweight men wishing to restore normal testicular function. It currently has negative earnings.

Baldwin Brothers Inc Ma holds 0% of its portfolio in Repros Therapeutics Inc. for 1,750 shares. Bank Of America Corp De owns 24,992 shares or 0% of their US portfolio. Moreover, Bank Of Montreal Can has 0% invested in the company for 1,000 shares. The New York-based Bank Of New York Mellon Corp has invested 0% in the stock. Barclays Plc, a United Kingdom-based fund reported 124 shares.

Analysts await Acxiom Corporation (NASDAQ:ACXM) to report earnings on May, 15. They expect $0.04 EPS, up 33.33% or $0.01 from last year’s $0.03 per share. ACXM’s profit will be $3.15 million for 141.94 P/E if the $0.04 EPS becomes a reality. After $0.17 actual EPS reported by Acxiom Corporation for the previous quarter, Wall Street now forecasts -76.47% negative EPS growth.

Insider deal totalling exactly $2,308 U.S Dollars was revealed online in a public document submitted to the DC-based SEC on 30/03/2018. According to which, John Battelle, the director of Acxiom Corp also an insider of the public firm had acquired a total of 100 shares – ( at $23.1 for each one share ). John Battelle now has rights to 34,017 shares which are equivalent to around 0.04% of the Arkansas-Company’s market cap.

The stock decreased 19.04% or $5.34 during the last trading session, reaching $22.71. About 17.44M shares traded or 1887.94% up from the average. Acxiom Corporation (NASDAQ:ACXM) has risen 11.14% since March 30, 2017 and is uptrending. It has underperformed by 0.41% the S&P500.

Investors sentiment decreased to 1.13 in 2017 Q4. Its down 0.42, from 1.55 in 2017Q3. It is negative, as 18 investors sold Acxiom Corporation shares while 62 reduced holdings. 31 funds opened positions while 59 raised stakes. 70.43 million shares or 3.16% less from 72.72 million shares in 2017Q3 were reported. Jacobs Levy Equity Mngmt, New Jersey-based fund reported 51,110 shares. Susquehanna International Grp Limited Liability Partnership stated it has 0% in Acxiom Corporation (NASDAQ:ACXM). Sei Invests holds 238,247 shares. Zurcher Kantonalbank (Zurich Cantonalbank), Switzerland-based fund reported 5,011 shares. Regions stated it has 300 shares. Montana-based First Interstate Bank has invested 0.01% in Acxiom Corporation (NASDAQ:ACXM). Earnest Prtnrs Ltd Llc has 0.13% invested in Acxiom Corporation (NASDAQ:ACXM) for 474,227 shares. Weiss Multi stated it has 0.14% of its portfolio in Acxiom Corporation (NASDAQ:ACXM). 53,831 were accumulated by Prudential Financial. Mariner Wealth Limited Liability Corporation holds 21,958 shares. Art Advisors Limited Co has invested 0.03% in Acxiom Corporation (NASDAQ:ACXM). Teacher Retirement System Of Texas has invested 0% in Acxiom Corporation (NASDAQ:ACXM). Goldman Sachs Grp Incorporated holds 0% of its portfolio in Acxiom Corporation (NASDAQ:ACXM) for 304,822 shares. Whittier Of Nevada stated it has 1,200 shares. Highbridge Cap Mgmt holds 0.01% or 22,290 shares.

Acxiom Corporation operates as a technology and enablement services firm in the United States, Europe, the Asia-Pacific, and internationally. The company has market cap of $1.79 billion. The firm operates through three divisions: Connectivity, Audience Solutions, and Marketing Services. It has a 184.63 P/E ratio. The Connectivity segment provides a foundational identity resolution layer, which enables its clients to identify and reach clients across channels and measure the impact of marketing on sales.

Among 6 analysts covering Acxiom Corporation (NASDAQ:ACXM), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Acxiom Corporation has $39 highest and $20 lowest target. $34.60’s average target is 52.36% above currents $22.71 stock price. Acxiom Corporation had 22 analyst reports since August 7, 2015 according to SRatingsIntel. Stephens maintained the shares of ACXM in report on Friday, February 16 with “Buy” rating. The firm earned “Buy” rating on Wednesday, January 24 by Stephens. William Blair maintained the stock with “Buy” rating in Thursday, March 8 report. As per Friday, August 5, the company rating was upgraded by BMO Capital Markets. Dougherty & Company initiated the shares of ACXM in report on Tuesday, May 24 with “Buy” rating. The rating was maintained by BMO Capital Markets on Wednesday, February 7 with “Outperform”. The stock of Acxiom Corporation (NASDAQ:ACXM) has “Buy” rating given on Wednesday, June 14 by Cantor Fitzgerald. Stephens maintained Acxiom Corporation (NASDAQ:ACXM) rating on Wednesday, February 7. Stephens has “Buy” rating and $31.0 target. The stock of Acxiom Corporation (NASDAQ:ACXM) has “Buy” rating given on Friday, September 22 by Cantor Fitzgerald. BMO Capital Markets maintained it with “Buy” rating and $32.0 target in Monday, September 11 report.

Acxiom Corporation (NASDAQ:ACXM) Institutional Positions Chart